Fig. 1From: A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinomaThe clinical and network pharmacology process of ZLJT in delaying drug resistance in advanced lung adenocarcinoma. A Clinical research findings. B Network pharmacology and molecular dockingBack to article page